-
PRAC highlights April 2021
PRAC highlights April 2021
-
PRAC highlights April 2021
PRAC highlights April 2021
Outcomes from the April meeting cover all aspects of the risk management of the use of medicines, including COVID-19 vaccines
-
COVID-19 AstraZeneca vaccine - PRAC conclusion
COVID-19 AstraZeneca vaccine - PRAC conclusion
-
COVID-19 AstraZeneca vaccine - PRAC conclusion
COVID-19 AstraZeneca vaccine - PRAC conclusion
EMA’s safety committee (PRAC) has concluded its review of very rare cases of unusual blood clots. The PRAC has recommended further updates to the product information for the vaccine.
-
Workshop on real-world metadata for regulatory purposes
Workshop on real-world metadata for regulatory purposes
-
Workshop on real-world metadata for regulatory purposes
Workshop on real-world metadata for regulatory purposes
Follow our workshop on 12 April, to gather feedback on a preliminary list of metadata required for characterising real-world data sources and on the process for collecting metadata
-
Public meeting on COVID-19 vaccines
Public meeting on COVID-19 vaccines
-
Public meeting on COVID-19 vaccines
Public meeting on COVID-19 vaccines
A video recording and presentation slides are now available from EMA’s public meeting on COVID-19 vaccines on 26 March.
